Indefinite Delivery Contract HHSD200201689086I

Merck Sharp & Dohme LLC, doing business as Merck, is the prime contractor on a Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs with the U.S. federal government. This IDV contract has a ceiling value of $6,073,473,460.00 and an ultimate completion date of June 1, 2025. Under this contract, Merck has been awarded numerous delivery orders and task orders by civilian federal agencies such as the Department of Veterans Affairs, Centers for Disease Control and...

This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs (VA) to Merck Sharp & Dohme LLC, doing business as Merck, a prominent pharmaceutical manufacturer and supplier to the federal government. The contract has a ceiling value of $5,837,161,580 and a period of performance through May 31, 2030. Under this IDV, Merck has been awarded multiple delivery orders by the VA's Veterans Integrated Service Network 5 for the supply of pharmaceutical products,...

This indefinite delivery contract was awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Centers for Disease Control and Prevention (CDC) Pittsburgh to procure a variety of pharmaceutical drugs and vaccines. The $5,863,720.17 contract has a period of performance from September 16, 2016 to September 15, 2021. Merck, a major pharmaceutical manufacturer, is providing the CDC with multiple vaccine types for both adult and pediatric populations under this IDV. This includes...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Merck Sharp & Dohme LLC, doing business as Merck, to provide 2019 Vaccines for Children. The contract has a potential value of $2,495,643,500.00 and a period of performance from April 1, 2019 to March 31, 2020. As a major pharmaceutical manufacturer, Merck will deliver a wide range of pediatric and adult vaccines to fulfill the Vaccines for...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract, valued at a ceiling of $66,688,290, is for the procurement of adult vaccines under the VACCINES major program code. The contract has a period of performance from July 1, 2025 to June 30, 2026. As an established federal contractor, Merck holds several significant IDVs with the CDC,...

This Other Transaction Agreement for Prototype was awarded by the Joint PEO Chemical and Biological Defense, a defense agency, to Merck Sharp & Dohme LLC, a major pharmaceutical manufacturer, for the development of molnupiravir as an oral therapeutic to treat Venezuelan equine encephalitis virus. The $39,111,329.00 contract has an award date of March 14, 2025 and does not utilize any set-asides. Merck is an experienced federal contractor, holding several Indefinite Delivery Vehicles with...

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a $2,993,341,000 ceiling value and a period of performance from April 1, 2021 through March 31, 2022. The purpose of this IDC is to provide a range of standard pediatric vaccines required to support immunization...

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center (NAC), a civilian federal agency, to Merck Sharp & Dohme LLC, doing business as Merck, a prominent pharmaceutical manufacturer. The $15,000,000 BPA is for the procurement of the cancer drug Welireg (belzutifan) and does not utilize any set-aside designations, indicating an open and competitive award process. The BPA has an ultimate completion date of July 7, 2025 and was awarded on August 9, 2022. Merck, a...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a ceiling value of $4,116,159,200 and a period of performance from April 1, 2025 to March 30, 2026. The IDC is for the procurement of standard commercial pediatric vaccines to support the Vaccines for Children (VFC) program, which provides immunizations...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Merck Sharp & Dohme Corp., a subsidiary of Schering Plough Corporation. The contract has a ceiling value of $1,465,459,641.64 and a period of performance from July 1, 2009 to June 30, 2010. The IDC is focused on providing VFA 2009, which likely refers to vaccine-related products and services. Merck Sharp & Dohme Corp. has been awarded multiple...